Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (83163)	2/16/2000 12:40:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

MATX, RZYM From February 9, Watch list. RZYM soared on Tuesday and is continued its ascent. MATX will most likely sit proudly in any 'intermediate-long term' portfolio. These are NOT one day wonders. Its important to watch biotechs for consistency and not just get in because they might be up one day. 6> RZYM - RIBOZYME PHARMACEUTICALS INC .DBI Price= 20.6 VL/30= 324.6 %Rnge= 94.0 Sto9V= 85.4 W14dV= 73.9 %Hi4 = 100.0 1-Dy = 116.1 50MA = 166.3 21MA = 133.7 good look biotech closed near high on very strong volume. RZYM is a second timer here. 7> MATX - MATRIX PHARMACEUTICAL INC .DBI Price= 8.9 VL/30= 664.1 %Rnge= 87.0 Sto9V= 86.7 W14dV= 79.3 %Hi4 = 100.0 1-Dy = 115.3 50MA = 160.1 21MA = 133.4 Low priced, chart is a little toppy but volume and company is impressive